Delhi | 25°C (windy)

Market Movers: What's Shaking Up the Stock Market Today?

  • Nishadil
  • November 24, 2025
  • 0 Comments
  • 4 minutes read
  • 1 Views
Market Movers: What's Shaking Up the Stock Market Today?

Well, here we are again, staring down another trading day, and wouldn't you know it, the market is absolutely teeming with interesting stories. For investors trying to keep a finger on the pulse, Friday, November 24th, brings a fresh batch of companies into the spotlight, each with its own unique reason for making waves. Let's dive in and see what's truly worth watching today.

Kicking things off, we've got one of India's IT behemoths, TCS, or Tata Consultancy Services, which has been quite generous lately. The company has announced an interim dividend of a cool Rs 9 per share. Now, that's definitely something that catches the eye, especially for those long-term holders. Just remember, the ex-date for this is set for November 28th, so keep that in mind if you're looking to participate.

Shifting gears a bit, the infrastructure sector continues to show signs of robust activity. Rail Vikas Nigam (RVNL), for instance, has just bagged a rather substantial order. We're talking about a project worth Rs 196.27 crore from Chennai Metro Rail for constructing an elevated viaduct and stations. This is a significant win, showcasing the ongoing push in urban development and infrastructure, and it’s certainly good news for RVNL's order book, don't you think?

And speaking of infrastructure, another name making headlines is HG Infra Engineering. They've just been declared the lowest bidder for a National Highways Authority of India (NHAI) project in Andhra Pradesh, valued at a whopping Rs 522.02 crore. Being the lowest bidder often bodes well for securing the project, so it’s definitely one to watch for further developments. It just goes to show you how much work is happening on our roads and highways across the country.

Now, let's talk about the power sector, always a hot topic. Tata Power has an important board meeting slated for November 28th. What's on the agenda, you ask? Well, they're set to consider raising funds through various avenues, be it a rights issue, a preferential issue, a Qualified Institutional Placement (QIP), or perhaps even debt. Such fundraising activities are often aimed at fueling future growth and expansion, so this meeting could set the stage for their next big moves.

On a slightly different, more cautious note, the pharmaceutical sector is seeing some regulatory updates. Both Natco Pharma and Lupin have recently faced inspections by the US FDA. Natco Pharma's Kothur formulation facility completed its inspection with two observations, while Lupin's Aurangabad manufacturing facility received four observations. And it's not just them; Shilpa Medicare also received a Form 483 with six observations for its Jadcherla facility. For pharma companies, these observations are standard procedure, but the number and nature of them are always scrutinised by investors. It's a reminder of the strict compliance environment in the global pharmaceutical market.

Last but certainly not least, a major development is brewing around IDBI Bank. The government is reportedly looking to offload a 45.48% stake, with LIC also planning to divest its 49.24% holding. This isn't small potatoes; it's a strategic divestment that could significantly change the bank's ownership structure. The board is actually meeting on November 28th to deliberate on this very strategic divestment, so expect this one to be a big conversation starter.

Beyond these headline-grabbers, several companies are also set to declare their Q2 results today. Keep an eye out for earnings reports from names like Balrampur Chini Mills, Gujarat State Petronet, Hindustan Aeronautics, Jubilant Ingrevia, Kalyan Jewellers, NCC, Redington, and Stove Kraft. Earnings season always brings its own set of surprises, good and bad, and these results could certainly influence broader market sentiment. As always, do your own due diligence, and Happy Trading!

Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on